Search

Farley J. Abad

Examiner (ID: 14201, Phone: (571)270-3425 , Office: P/2181 )

Most Active Art Unit
2181
Art Unit(s)
2181
Total Applications
1076
Issued Applications
864
Pending Applications
101
Abandoned Applications
140

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 626790 [patent_doc_number] => 07135173 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-14 [patent_title] => 'Antiviral activity of Shiga toxin' [patent_app_type] => utility [patent_app_number] => 10/325664 [patent_app_country] => US [patent_app_date] => 2002-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 20956 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/135/07135173.pdf [firstpage_image] =>[orig_patent_app_number] => 10325664 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/325664
Antiviral activity of Shiga toxin Dec 17, 2002 Issued
10/311580 Assembly of wild-type and chimeric influenza virus-like particles (vlps) Dec 15, 2002 Abandoned
Array ( [id] => 6633021 [patent_doc_number] => 20030211467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Methods and compositions for detecting hepatitis E virus' [patent_app_type] => new [patent_app_number] => 10/319745 [patent_app_country] => US [patent_app_date] => 2002-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 40273 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211467.pdf [firstpage_image] =>[orig_patent_app_number] => 10319745 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/319745
Methods and compositions for detecting hepatitis E virus Dec 12, 2002 Abandoned
Array ( [id] => 6741006 [patent_doc_number] => 20030158375 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'G-CSF polypeptides and conjugates' [patent_app_type] => new [patent_app_number] => 10/318966 [patent_app_country] => US [patent_app_date] => 2002-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 35742 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20030158375.pdf [firstpage_image] =>[orig_patent_app_number] => 10318966 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/318966
G-CSF polypeptides and conjugates Dec 12, 2002 Abandoned
Array ( [id] => 6830297 [patent_doc_number] => 20030181355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Method for inhibition of viral infection' [patent_app_type] => new [patent_app_number] => 10/317644 [patent_app_country] => US [patent_app_date] => 2002-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10775 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20030181355.pdf [firstpage_image] =>[orig_patent_app_number] => 10317644 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/317644
Method for inhibition of viral infection Dec 10, 2002 Abandoned
Array ( [id] => 6639466 [patent_doc_number] => 20030212039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Method for preventing vascular disease' [patent_app_type] => new [patent_app_number] => 10/309761 [patent_app_country] => US [patent_app_date] => 2002-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14582 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20030212039.pdf [firstpage_image] =>[orig_patent_app_number] => 10309761 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/309761
Method for preventing vascular disease Dec 3, 2002 Abandoned
Array ( [id] => 6639466 [patent_doc_number] => 20030212039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Method for preventing vascular disease' [patent_app_type] => new [patent_app_number] => 10/309761 [patent_app_country] => US [patent_app_date] => 2002-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14582 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20030212039.pdf [firstpage_image] =>[orig_patent_app_number] => 10309761 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/309761
Method for preventing vascular disease Dec 3, 2002 Abandoned
Array ( [id] => 6702150 [patent_doc_number] => 20030225030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Non-liquid vitamin compositions' [patent_app_type] => new [patent_app_number] => 10/309802 [patent_app_country] => US [patent_app_date] => 2002-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14575 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20030225030.pdf [firstpage_image] =>[orig_patent_app_number] => 10309802 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/309802
Non-liquid vitamin compositions Dec 3, 2002 Abandoned
Array ( [id] => 6770410 [patent_doc_number] => 20030216350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Method for prevention of neuropsychiatric disorders' [patent_app_type] => new [patent_app_number] => 10/309752 [patent_app_country] => US [patent_app_date] => 2002-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14581 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20030216350.pdf [firstpage_image] =>[orig_patent_app_number] => 10309752 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/309752
Method for prevention of neuropsychiatric disorders Dec 3, 2002 Abandoned
Array ( [id] => 6702150 [patent_doc_number] => 20030225030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Non-liquid vitamin compositions' [patent_app_type] => new [patent_app_number] => 10/309802 [patent_app_country] => US [patent_app_date] => 2002-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14575 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20030225030.pdf [firstpage_image] =>[orig_patent_app_number] => 10309802 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/309802
Non-liquid vitamin compositions Dec 3, 2002 Abandoned
Array ( [id] => 6770410 [patent_doc_number] => 20030216350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Method for prevention of neuropsychiatric disorders' [patent_app_type] => new [patent_app_number] => 10/309752 [patent_app_country] => US [patent_app_date] => 2002-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14581 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20030216350.pdf [firstpage_image] =>[orig_patent_app_number] => 10309752 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/309752
Method for prevention of neuropsychiatric disorders Dec 3, 2002 Abandoned
Array ( [id] => 6664547 [patent_doc_number] => 20030203873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'Method for treatment of neuropsychiatric disorders' [patent_app_type] => new [patent_app_number] => 10/309748 [patent_app_country] => US [patent_app_date] => 2002-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14571 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20030203873.pdf [firstpage_image] =>[orig_patent_app_number] => 10309748 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/309748
Method for treatment of neuropsychiatric disorders Dec 3, 2002 Abandoned
Array ( [id] => 6711535 [patent_doc_number] => 20030171284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Derivatives of growth hormone and related proteins, and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/298148 [patent_app_country] => US [patent_app_date] => 2002-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37953 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171284.pdf [firstpage_image] =>[orig_patent_app_number] => 10298148 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/298148
Derivatives of growth hormone and related proteins, and methods of use thereof Nov 14, 2002 Issued
Array ( [id] => 7363764 [patent_doc_number] => 20040091851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'HCV peptide compositions' [patent_app_type] => new [patent_app_number] => 10/291734 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 166 [patent_figures_cnt] => 166 [patent_no_of_words] => 73129 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20040091851.pdf [firstpage_image] =>[orig_patent_app_number] => 10291734 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/291734
HCV peptide compositions Nov 11, 2002 Abandoned
Array ( [id] => 6765247 [patent_doc_number] => 20030099645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Naturally occuring IgM antibodies that bind to membrane receptors on lymphocytes' [patent_app_type] => new [patent_app_number] => 10/292002 [patent_app_country] => US [patent_app_date] => 2002-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13041 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20030099645.pdf [firstpage_image] =>[orig_patent_app_number] => 10292002 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/292002
Naturally occuring IgM antibodies that bind to membrane receptors on lymphocytes Nov 6, 2002 Abandoned
Array ( [id] => 971866 [patent_doc_number] => 06936251 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-30 [patent_title] => 'Peptide reagent for the detection of human cytomegalovirus (CMV)' [patent_app_type] => utility [patent_app_number] => 10/288220 [patent_app_country] => US [patent_app_date] => 2002-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 8256 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/936/06936251.pdf [firstpage_image] =>[orig_patent_app_number] => 10288220 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/288220
Peptide reagent for the detection of human cytomegalovirus (CMV) Nov 4, 2002 Issued
Array ( [id] => 6696374 [patent_doc_number] => 20030108568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Long lasting synthetic glucagon-like peptide {GLP-1}' [patent_app_type] => new [patent_app_number] => 10/288340 [patent_app_country] => US [patent_app_date] => 2002-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20390 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20030108568.pdf [firstpage_image] =>[orig_patent_app_number] => 10288340 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/288340
Long lasting synthetic glucagon-like peptide {GLP-1} Nov 3, 2002 Issued
Array ( [id] => 1096286 [patent_doc_number] => 06821949 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-23 [patent_title] => 'Long lasting synthetic glucagon-like peptide (GLP-1)' [patent_app_type] => B2 [patent_app_number] => 10/287892 [patent_app_country] => US [patent_app_date] => 2002-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21975 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/821/06821949.pdf [firstpage_image] =>[orig_patent_app_number] => 10287892 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/287892
Long lasting synthetic glucagon-like peptide (GLP-1) Nov 3, 2002 Issued
Array ( [id] => 7025357 [patent_doc_number] => 20050019751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Screening for hepatitis c virus entry inhibitors' [patent_app_type] => utility [patent_app_number] => 10/494555 [patent_app_country] => US [patent_app_date] => 2002-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8875 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20050019751.pdf [firstpage_image] =>[orig_patent_app_number] => 10494555 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/494555
Screening for hepatitis c virus entry inhibitors Oct 31, 2002 Abandoned
10/281341 Activation of HCV-specific T cells Oct 24, 2002 Abandoned
Menu